Related Experiment Video

Updated: Aug 12, 2026

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
07:25

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

[Age and dyslipidemia as risk factors in transcutaneous transluminal angioplasty]

V I Prokubovskiĭ, V A Petukhov, S G Dubovik

    Grudnaia I Serdechno-Sosudistaia Khirurgiia
    |January 1, 1992
    PubMed

    Insights

    Transcutaneous transluminal angioplasty (TTA) for lower extremity atherosclerosis shows age and dyslipidemia do not impact immediate outcomes. However, these factors correlate with long-term reocclusion, highlighting the need for lipid management.

    Area of Science:

    • Vascular Surgery
    • Cardiovascular Medicine
    • Interventional Radiology

    Context:

    • Atherosclerosis obliterans of the lower extremities affects numerous patients, necessitating effective treatment strategies.
    • Transcutaneous transluminal angioplasty (TTA) is a common endovascular intervention for this condition.
    • Understanding factors influencing TTA outcomes is crucial for patient management.

    Purpose:

    • To analyze the immediate and late outcomes of TTA in patients with lower extremity atherosclerosis.
    • To identify risk factors affecting both early and long-term results of TTA.
    • To establish the role of dyslipidemia correction in improving TTA efficacy.

    Summary:

    • This study evaluated 147 patients undergoing TTA for lower extremity atherosclerosis.
    • Immediate postoperative outcomes were not significantly affected by age or dyslipidemia.
    • Long-term follow-up revealed a positive correlation between age, lipid metabolic disturbances, and TTA reocclusion time.

    Impact:

    • Correcting dyslipidemias is essential for enhancing long-term TTA success rates in patients with atherosclerosis obliterans.
    • The findings underscore the importance of comprehensive patient assessment and management, including lipid control.
    • This research provides evidence-based recommendations for optimizing endovascular treatment strategies.

    More Related Videos

    Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation06:47

    Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

    Published on: January 28, 2021

    Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome06:04

    Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome

    Published on: September 27, 2024

    Related Concept Videos

    Coronary Artery Disease I: Introduction01:30

    Coronary Artery Disease I: Introduction

    Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
    Coronary Artery Disease II: Pathophysiology01:26

    Coronary Artery Disease II: Pathophysiology

    Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
    Angina IV: Management01:26

    Angina IV: Management

    IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
    Atherosclerosis I: Introduction01:30

    Atherosclerosis I: Introduction

    Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
    Atherosclerosis III: Management01:26

    Atherosclerosis III: Management

    Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
    Transient Ischemic Attack l: Introduction01:26

    Transient Ischemic Attack l: Introduction

    A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...